Update on PI3K inhibitors for CLL: Idelalisib, copanlisib, duvelisib, and umbralisib
Earn CME for related activities: https://www.naccme.com/oln
In this presentation from the 'Navigating the Evolving Therapeutic Landscape of CLL: Strategies for the Optimal Application of Emerging Agents and Combinations in Practice’ symposium, Dr. Jennifer R. Brown provides an update on PI3K inhibitors for CLL.
© 2018 Imedex, an HMP Company
Видео Update on PI3K inhibitors for CLL: Idelalisib, copanlisib, duvelisib, and umbralisib канала HMP Education
In this presentation from the 'Navigating the Evolving Therapeutic Landscape of CLL: Strategies for the Optimal Application of Emerging Agents and Combinations in Practice’ symposium, Dr. Jennifer R. Brown provides an update on PI3K inhibitors for CLL.
© 2018 Imedex, an HMP Company
Видео Update on PI3K inhibitors for CLL: Idelalisib, copanlisib, duvelisib, and umbralisib канала HMP Education
Показать
Комментарии отсутствуют
Информация о видео
Другие видео канала
Practical Application of Negative Pressure Wound Therapy with Instillation
Segment 2: Risk Assessment in Prostate Cancer
Rectal cancer: What is next in the field of radiotherapy?
Improving Outcomes in Atrial Fibrillation with Optimal Antiarrhythmic Approaches
Virtual Patient Case: Carcinoid Syndrome #1 - Initial Presentation
What Determines “Quality” for Endoscopy Reporting in IBD Patients?
Current and Evolving Therapeutic Landscape of IBD
Molecular Alterations and New Drugs in Bile Duct Cancer
Multiple Myeloma Update: Maintenance Therapy
Optimizing IBD Management: New and Emerging Therapeutic Targets
Can We Increase the Immunogenicity in MSS CRC?
Optimizing Biological Therapies in the Modern Era
Key Insights in Chronic Lymphocytic Leukemia
Hydroxyurea Intolerance/Resistance in Polycythemia vera
Acute Myeloid Leukemia: Panel Discussion
Do We Know the Cause(s) of IBD: Update on the Microbiome with the RISK Study as a Model
What is New in Waldenström Macroglobulinemia? How I Treat it
ADHD: Essential Tools for Recognizing and Treating Patients From Young Adulthood and Beyond
Immune Function in CLL: What is Wrong and Why?
MRD in Acute Myeloid Leukemia
Migraine Prevention: New Opportunities for Pain Relief